Increased risk of ADHD in families with ASD

被引:0
|
作者
Mathilde Septier
Hugo Peyre
Fréderique Amsellem
Anita Beggiato
Anna Maruani
Marion Poumeyreau
Anouck Amestoy
Isabelle Scheid
Alexandru Gaman
Federico Bolognani
Garry Honey
Céline Bouquet
Myriam Ly-Le Moal
Manuel Bouvard
Marion Leboyer
Thomas Bourgeron
Richard Delorme
机构
[1] Robert Debré Hospital,Department of Child and Adolescent Psychiatry
[2] APHP,Laboratoire de Sciences Cognitives et Psycholinguistique (ENS, EHESS, CNRS), Ecole Normale Supérieure
[3] Centre de Psychiatrie et Neurosciences,Human Genetics and Cognitive Functions
[4] INSERM U894 Team 1,Autism Expert Centre
[5] PSL Research University,Fondation FondaMental
[6] Institut Pasteur,Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel
[7] Charles Perrens Hospital,Department of Adult Psychiatry
[8] French National Science Foundation,undefined
[9] F. Hoffmann-La Roche Ltd.,undefined
[10] Institut National de la Santé et de la Recherche Médicale (INSERM),undefined
[11] U955,undefined
[12] Institut Mondor de Recherche Biomédicale,undefined
[13] Psychiatrie Translationnelle,undefined
[14] Henri Mondor and Albert Chenevier Hospital,undefined
[15] Paris 7 Denis Diderot University,undefined
[16] Institut Roche,undefined
来源
European Child & Adolescent Psychiatry | 2019年 / 28卷
关键词
Attention deficit hyperactivity disorder; Autism spectrum disorder; Familial aggregation; Siblings;
D O I
暂无
中图分类号
学科分类号
摘要
Attention Deficit and Hyperactive Disorder (ADHD) and Autism Spectrum Disorders (ASD) are frequent comorbid neurodevelopmental conditions and the overlap between both disorders remains to be delineated. A more complete understanding of the shared genetic and environmental factors is needed. Using a family-based method, we evaluated the risk of ADHD in a group of relatives with an ASD proband (ASD−) and a group of relatives with an ASD and ADHD proband (ASD+). We enrolled 1245 individuals in the study: 499 probands, their 746 first-degree relatives and 140 controls. We used a multivariate generalized estimating equation (GEE) model, in which the dependent variable was the ADHD diagnosis in the relatives and the independent variable the ASD+ or ASD− in probands. We adjusted for sociodemographic factors (age, sex, IQ) and for the nature of the familial relationship with the affected proband (parent or sibling). Among the probands, there were 287 ASD− and 212 ASD+ individuals. ADHD was more frequent in relatives (19%) than in the control group (7%) (p = 0.001). The risk of ADHD was higher in the ASD+ relatives group than in the ASD− relatives group (GEE model OR 1.58 [95% CI 1.04–2.38], p = 0.032). This result was found in parents (OR 1.96 [95% CI  1.14–3.36], but not in siblings (OR 1.28 [95% CI 0.84–1.94], p = 0.434). Our study provides a representative estimate of the family distribution of ADHD in relatives of ASD probands but supports the modest effect of shared genetic and environmental factors between both disorders.
引用
收藏
页码:281 / 288
页数:7
相关论文
共 50 条
  • [31] Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
    Ventura, Patrizia
    de Giambattista, Concetta
    Trerotoli, Paolo
    Cavone, Maddalena
    Di Gioia, Alessandra
    Margari, Lucia
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [32] Executive Function in Autism: Association with ADHD and ASD Symptoms
    Lee, Rachel R.
    Ward, Anthony R.
    Lane, David M.
    Aman, Michael G.
    Loveland, Katherine A.
    Mansour, Rosleen
    Pearson, Deborah A.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2023, 53 (02) : 688 - 700
  • [33] The Effects of Vitamin Therapy on ASD and ADHD: A Narrative Review
    Poudineh, Mohadeseh
    Parvin, Sadaf
    Omidali, Mehrnia
    Nikzad, Farhad
    Mohammadyari, Fatemeh
    Ranjbar, Fatemeh Sadeghi Poor
    Rasouli, Fayaz
    Nanbakhsh, Sepehr
    Olangian-Tehrani, Sepehr
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (05) : 711 - 735
  • [34] Disorder in ADHD and ASD Post-COVID-19
    Nash, Carol
    COVID, 2021, 1 (01): : 153 - 165
  • [35] RETRACTED: Rates of comorbid symptoms in children with ASD, ADHD, and comorbid ASD and ADHD (Retracted article. See vol. 133, 2023)
    Jang, Jina
    Matson, Johnny L.
    Williams, Lindsey W.
    Tureck, Kim
    Goldin, Rachel L.
    Cervantes, Paige E.
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2013, 34 (08) : 2369 - 2378
  • [36] The discriminate value of event-related potentials in executive function of ADHD and comorbidity of ADHD and ASD
    Tan, Chuanxue
    Zhou, Huimin
    Yang, Miao
    Li, Chunyang
    Chen, Huanli
    He, Li
    Yang, Ting
    Chen, Jie
    Zhang, Jie
    Li, Tingyu
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [37] Family Quality of Life Perceived by Mothers of Children with ASD and ADHD
    Romaniuk, Alyssa
    Ward, Michelle
    Henrikson, Brenna
    Cochrane, Karis
    Theule, Jennifer
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2024, 55 (02) : 510 - 519
  • [38] Employment experiences of parents of children with ASD or ADHD: an exploratory study
    Hill, Elisabeth L.
    Jones, Alice P.
    Lang, Jane
    Yarker, Joanna
    Patterson, Allyson
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES, 2015, 61 (03) : 166 - 176
  • [39] A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD
    Purkayastha, Priyanka
    Malapati, Aruna
    Yogeeswari, Perumal
    Sriram, Dharmarajan
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (15) : 1850 - 1859
  • [40] Family Quality of Life Perceived by Mothers of Children with ASD and ADHD
    Alyssa Romaniuk
    Michelle Ward
    Brenna Henrikson
    Karis Cochrane
    Jennifer Theule
    Child Psychiatry & Human Development, 2024, 55 : 510 - 519